Laid off from GSK.

Research Triangle Park lost jobs in 2014 when GSK consolidated drug research in Philadelphia and England, and Cambridge, Massachusetts, lost manufacturing jobs in 2025 when that work moved to Pennsylvania. Staff at Human Genome Sciences and Stiefel were cut in the same year GSK bought those companies.

What we know about GSK severance and layoffs

  • Around 350 R&D jobs at most in GSK's February 2026 UK and US cuts
  • 150 Cambridge, Massachusetts jobs in GSK's July 2025 notice as manufacturing moved to Pennsylvania
  • 650 US jobs cut in September 2018, 450 of them in field sales
  • 900 Research Triangle Park jobs in GSK's December 2014 North Carolina filing
  • 114 and 97 Rockville jobs in 2012 notices after GSK bought Human Genome Sciences
  • 155 Stiefel jobs in Duluth, Georgia, laid off in November 2009, after GSK's purchase

The most recent GSK layoff we've found

GSK unveiled a three-year plan in July 2026 aimed at saving about $2.5 billion a year. Job cuts would be part of it, a GSK spokesperson told BioPharma Dive, alongside new research roles, with employees hearing the details before any public count.

What GSK layoffs have meant for employees

GSK's February 2026 research cuts came from an overhaul in which, the Press Association reported, the company had been removing duplicated roles since it moved to merge its vaccines and specialty medicines operations. GSK explained them the way it had explained the 2025 Cambridge layoffs to MassLive, as "making sure we have the right people in the right teams." GSK used the same sentence for a manufacturing move in Massachusetts in July 2025 and for research cuts in Britain and the US the following February.

In 2014 and again in 2025, a GSK site lost jobs because the work it did went to another GSK site. Jobs at Research Triangle Park were cut as drug research consolidated in Philadelphia and Stevenage, Fortune reported, with several hundred US commercial jobs going as well and relocation to other sites offered to some staff. In Cambridge, GSK kept research at its Binney Street site and moved the site's manufacturing to Marietta, Pennsylvania. If your GSK separation date is tied to a site whose work is moving, relocation is something GSK has offered before, in 2014, though to some staff and not all.

GSK has also cut staff at companies soon after buying them. It bought Seattle's Corixa in 2005 and quickly laid off its 110 local employees, then, the Seattle Times reported in 2006, decided to close the Bothell vaccine lab that came with ID Biomedical ten months after that purchase. The Bothell work had never fit GSK's plans, and the company had tried to sell the operation before closing it. Stiefel was to keep working under the name "Stiefel, a GSK company," according to GSK's completion release, and its Duluth, Georgia site lost jobs before that year was out. Human Genome Sciences was cutting Rockville jobs within months of GSK's 2012 takeover, according to the Baltimore Business Journal, in what GSK called an integration. If GSK has just bought the company you work for, those are the cases on record, and in each the cuts came in the year of the deal or the year after.

Several of GSK's US rounds came under company-wide cost programs. The 2014 cuts were part of a restructuring GSK had announced that October to save $1.6 billion a year over three years, according to the same Reuters report, and the 2018 round belonged to a program that, as a pharmaphorum report put it, GSK first mentioned that July with the aim of freeing money for research. In both years, the US notices and the press reports of who was cut came within months of the program's announcement.

The first notice of a GSK program hasn't always been its last. GSK was still filing notices for its December 2014 reductions in early 2015, including one in Pennsylvania that February for jobs near Philadelphia, as BioSpace reported, and Human Genome Sciences told Maryland in October 2012 that more layoffs could follow its second notice, according to the same Baltimore Business Journal report. Even within one notice, Cambridge's exits were spread from October 2025 into March 2026. For anyone kept on after a first GSK notice, a second one followed in both the 2014 and the 2012 rounds.

For GSK staff in North Carolina, Pennsylvania or Massachusetts, there's more on North Carolina unemployment benefits, Pennsylvania's and Massachusetts'. If GSK offers you a package, we have more on negotiating severance, and on how COBRA works if GSK health insurance stops when the job does.

A sourced history of GSK layoffs

  • February 2026, research cuts in the UK and US

    GSK was cutting up to around 350 research jobs in Britain and the US, about 50 so far at its Stevenage hub, according to the Press Association, with final numbers for both countries still being set when it reported.

  • July 2025, Cambridge manufacturing layoffs

    GSK told Massachusetts that 150 Cambridge jobs would end between October 4, 2025, and March 31, 2026, and a spokesperson told MassLive its Binney Street site would turn to research only as manufacturing moved to Marietta, Pennsylvania.

  • September 2018, US sales and office cuts

    GSK cut 650 US jobs, including 450 field sales roles nationwide, 100 at Research Triangle Park and 100 back-office jobs in Philadelphia, according to a pharmaphorum report, and expected most to leave by the end of November.

  • December 2014, Research Triangle Park research cuts

    A filing with North Carolina covered 900 Research Triangle Park jobs, Fortune reported in December 2014, as drug research was consolidated in Philadelphia and Stevenage, England. Another 180 North Carolina cuts followed in March 2015, part of the same reductions according to a GSK spokeswoman quoted by BioSpace.

  • 2012, Human Genome Sciences cuts after GSK's purchase

    Human Genome Sciences told Maryland of 114 Rockville cuts and then 97 more from December 15, after GSK completed its takeover that summer, and a GSK spokesman told the Baltimore Business Journal the cuts were part of the integration.

  • November 2009, Stiefel's Duluth, Georgia layoffs

    Stiefel Laboratories laid off 155 people in Duluth effective November 3, under a Georgia notice in our WARN tracker. GSK had bought all of Stiefel in the deal its July 2009 release announced.

  • October 2006, Bothell vaccine research closing

    GSK was closing the Bothell, Washington, vaccine-research operation it got with ID Biomedical and laying off about 70, the Seattle Times reported, a year after buying Corixa in Seattle and quickly laying off its 110 local employees.

What to do if you're laid off from GSK

GSK layoff and severance questions

What severance has GSK given laid-off employees?

GSK's 2018 notice to North Carolina said people losing jobs would be offered severance benefits, subsidized health insurance and outplacement support, according to a pharmaphorum report. In the 2014 Research Triangle Park cuts, BioSpace reported, about half of the R&D staff affected were offered positions at Parexel, a contract research organization, and those who took them kept working on GSK's campus.

Is GSK laying off employees in 2026?

Yes. GSK began cutting research roles across the UK and US in February 2026, according to the Press Association, and in July a spokesperson told BioPharma Dive that its new three-year savings plan would include job cuts. Our WARN tracker shows no GSK filing from 2026.

How many WARN notices has GSK filed since 2025?

GSK has 2 filings covering 158 jobs since the start of 2025, the July 2025 Cambridge, Massachusetts notice and an 8-job California notice dated September 29, 2025, according to our WARN tracker. All time, the tracker has 14 filings from GSK and companies it bought, 6 of them from those companies, the earliest a 2004 New Jersey notice.

Is Haleon part of GSK?

No. GSK completed the demerger of its consumer healthcare business into the Haleon Group on July 18, 2022, its July 2022 announcement said, so from that date the business belonged to Haleon. Some older notices under GSK's own name came from consumer plants it closed itself, among them the Clifton, New Jersey oral care plant, whose closing BioSpace reported in October 2013, with layoffs effective June 30, 2014 on New Jersey's list.

Sources for this page